#1029 2006 · US Food and Drug Administration · Food regulation / public health
The FDA didn't ban trans fat — it made companies print the number, and they reformulated
the problem
Trans fat was cheap, shelf-stable and legal, but invisible on any label a shopper could check
background
Partially hydrogenated oils, the main source of artificial trans fat, were cheap, extended shelf life, and were legal to use in essentially unlimited amounts — and by the 1990s a substantial body of research linked them to heart disease more strongly than saturated fat. None of that showed up anywhere a shopper could see: the Nutrition Facts panel introduced in 1990 broke out total fat and saturated fat, but trans fat had no line of its own, so two products with identical total fat could have very different trans fat content with no way to tell from the label.
Banning the ingredient outright would have meant defending, product by product and use by use, that no safe threshold existed — a scientifically and politically slower fight than the calorie-and-fat-content disclosures the FDA already required. The agency had a faster lever available: it didn't need to prove trans fat was unsafe at any level, only that consumers deserved to see how much of it was in what they were buying.
what everyone would do
The direct route was to prohibit partially hydrogenated oils outright, which meant establishing, ingredient by ingredient and use by use, that no safe level existed — a higher evidentiary and political bar than requiring disclosure, and one the FDA didn't clear for artificial trans fat as a whole until years after labeling had already reshaped the market.
what they saw
The FDA never outlawed the ingredient. It only required the gram count printed on a label people already read for calories, and food makers reformulated years ahead of the deadline to avoid the number.
the move
The FDA's 2003 rule, taking effect January 1, 2006, required a new mandatory line on the Nutrition Facts panel disclosing exact trans fat content per serving, in grams, on virtually all packaged food — placed directly beneath the existing saturated fat line, in the same format consumers already scanned when checking calories.
why it works
A mandatory disclosure line works on a manufacturer the same way a public report card works on a hospital: it doesn't change what's legal, it changes what's visible to a customer already comparing products side by side. Because trans fat could be engineered out of most recipes with substitute oils, and because 'trans fat 0g' reads as a selling point while any nonzero number reads as a liability next to a saturated-fat-free competitor, manufacturers had a direct commercial reason to reformulate before the number ever had to appear on their own product.
the payoff
Blood trans-fat levels in American adults fell 58% between 2000 and 2009, largely before and after mandatory labeling took effect.
where it breaks
It only works when reformulation is technically and economically feasible — for inputs with no viable substitute, disclosure just informs consumers of a risk they can't avoid buying around. It also depends on consumers actually reading and weighing the specific line item; for less familiar or less publicized metrics than trans fat (which arrived after years of prior news coverage priming the public to care), a new disclosure line can sit on the label unnoticed and unacted upon.
what came after
Manufacturers, including Kraft and Smucker's, reformulated widely in the two years before the 2006 deadline to avoid printing a trans fat number at all, restaurants followed under local pressure even where the label rule didn't apply to them, and the FDA later cited the labeling era's momentum when it moved to eliminate artificial trans fat from the food supply entirely by 2018.
references
- [1]Trans-fat blood levels plummet after FDA food-labeling regulationCenters for Disease Control and Prevention, 2012archive.cdc.gov
- [2]Trans-fat blood levels plummet after FDA food-labeling regulationThe Washington Post, 2012washingtonpost.com